NASDAQ:KMTS Kestra Medical Technologies (KMTS) Stock Price, News & Analysis $25.51 -0.58 (-2.22%) Closing price 04:00 PM EasternExtended Trading$25.55 +0.04 (+0.16%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Kestra Medical Technologies Stock (NASDAQ:KMTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get KMTS alerts:Sign Up Key Stats Today's Range$25.14▼$26.0650-Day Range$20.89▼$28.3552-Week Range$17.34▼$30.00Volume222,727 shsAverage Volume344,534 shsMarket Capitalization$1.52 billionP/E RatioN/ADividend YieldN/APrice Target$28.38Consensus RatingHold Company Overview Kestra Medical Technologies, Inc. is a medical device company focused on developing and commercializing technologies for patients at risk of sudden cardiac arrest. The company’s primary product is the ASSURE wearable cardioverter defibrillator, a wearable system designed to continuously monitor a patient’s heart rhythm and deliver an electrical shock when a life-threatening arrhythmia is detected. The ASSURE system is intended to provide temporary protection for patients who may be at elevated risk of sudden cardiac death but are not yet candidates for, or are awaiting, an implantable cardioverter-defibrillator. The product combines cardiac monitoring, arrhythmia detection and defibrillation capabilities in a wearable platform that can be used outside a hospital setting. Kestra Medical Technologies serves the cardiac-care market through relationships with physicians, hospitals and other healthcare providers. The company is headquartered in the United States and focuses on advancing wearable technologies intended to support remote patient care and improve protection for individuals vulnerable to serious cardiac arrhythmias.AI Generated. May Contain Errors. Read More Kestra Medical Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks33rd Percentile Overall ScoreKMTS MarketRank™: Kestra Medical Technologies scored higher than 33% of companies evaluated by MarketBeat, and ranked 750th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingHold Consensus RatingKestra Medical Technologies has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on no strong buy ratings, 4 buy ratings, 2 hold ratings, and 1 sell rating.Upside PotentialKestra Medical Technologies has a consensus price target of $28.38, representing about 11.2% upside from its current price of $25.51.Amount of Analyst CoverageKestra Medical Technologies has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Kestra Medical Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Kestra Medical Technologies are expected to grow in the coming year, from ($2.45) to ($2.12) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Kestra Medical Technologies is -9.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Kestra Medical Technologies is -9.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioKestra Medical Technologies has a P/B Ratio of 6.84. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.36% of the float of Kestra Medical Technologies has been sold short.Short Interest Ratio / Days to CoverKestra Medical Technologies has a short interest ratio ("days to cover") of 12.36, which indicates bearish sentiment.Change versus previous monthShort interest in Kestra Medical Technologies has recently decreased by 1.47%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldKestra Medical Technologies does not currently pay a dividend.Dividend GrowthKestra Medical Technologies does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.49 News SentimentKestra Medical Technologies has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Kestra Medical Technologies this week, compared to 3 articles on an average week. Company Ownership0.9 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Kestra Medical Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,802,688.00 in company stock.Percentage Held by Insiders5.30% of the stock of Kestra Medical Technologies is held by insiders.Percentage Held by InstitutionsKestra Medical Technologies has minimal institutional ownership at this time.Read more about Kestra Medical Technologies' insider trading history. Receive KMTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kestra Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KMTS Stock News HeadlinesKestra Medical Technologies (KMTS) Could Be 17% Undervalued Following Raised Revenue OutlookSeptember 21 at 12:31 AM | finance.yahoo.comKestra Medical (KMTS) Raises Outlook. Can Better Reimbursement Support Scale?September 17, 2026 | finance.yahoo.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.September 23 at 1:00 AM | Altimetry (Ad)Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down on Disappointing EarningsSeptember 17, 2026 | americanbankingnews.comKestra Medical Technologies (NASDAQ:KMTS) Earns "Buy" Rating from BTIG ResearchSeptember 17, 2026 | americanbankingnews.comAnalysts Are Bullish on Top NA Stocks: Kestra Medical Technologies Ltd. (KMTS), Humana (HUM)September 16, 2026 | theglobeandmail.comKestra Medical: Strong Scaling Story, But Profitability Still On The HorizonSeptember 16, 2026 | seekingalpha.comKestra Medical Technologies (NASDAQ:KMTS) Director Kevin Reilly Sells 2,932 SharesSeptember 11, 2026 | insidertrades.comSee More Headlines KMTS Stock Analysis - Frequently Asked Questions How have KMTS shares performed this year? Kestra Medical Technologies' stock was trading at $26.52 on January 1st, 2026. Since then, KMTS shares have decreased by 3.8% and is now trading at $25.51. How were Kestra Medical Technologies' earnings last quarter? Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) released its quarterly earnings data on Monday, September, 14th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.61) by $0.14. The business earned $30.97 million during the quarter. Kestra Medical Technologies had a negative net margin of 140.43% and a negative trailing twelve-month return on equity of 63.83%. Read the conference call transcript. When did Kestra Medical Technologies IPO? Kestra Medical Technologies (KMTS) raised $178 million in an IPO on Thursday, March 6th 2025. The company issued 11,882,352 shares at $14.00-$16.00 per share. Who are Kestra Medical Technologies' major shareholders? Top institutional shareholders of Kestra Medical Technologies include Corient Private Wealth LP (0.10%) and California State Teachers Retirement System (0.05%). Insiders that own company stock include Brian Daniel Webster, Traci S Umberger, Alfred J Ford Jr, Timothy P Moran, Vaseem Mahboob, Mary Kay Ladone, Raymond W Cohen, Jeffrey Lawrence Schwartz, Conor Hanley and Kevin C Reilly. View institutional ownership trends. How do I buy shares of Kestra Medical Technologies? Shares of KMTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings9/14/2026Today9/23/2026Fiscal Year End4/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 KMTS's financial health is in the Green zone, according to TradeSmith. KMTS has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:KMTS Previous SymbolNASDAQ:KMTS CIK1877184 Webwww.kestramedical.com Phone(425) 279-8002FaxN/AEmployees443Year Founded2021Price Target and Rating Average Price Target for Kestra Medical Technologies$28.38 High Price Target$32.00 Low Price Target$17.00 Potential Upside/Downside+11.2%Consensus RatingHold Rating Score (0-4)2.43 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($2.67) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$131.61 million Net Margins-140.43% Pretax Margin-140.14% Return on Equity-63.83% Return on Assets-44.76% Debt Debt-to-Equity Ratio0.33 Current Ratio4.69 Quick Ratio4.69 Sales & Book Value Annual Sales$95.13 million Price / Sales15.97 Cash FlowN/A Price / Cash FlowN/A Book Value$3.73 per share Price / Book6.84Miscellaneous Outstanding Shares59,560,000Free Float56,405,000Market Cap$1.52 billion OptionableN/A Beta0.62 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:KMTS) was last updated on 9/23/2026 by MarketBeat.com Staff. From Our PartnersReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...Decentralized Masters | SponsoredMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altuche...Paradigm Press | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kestra Medical Technologies, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kestra Medical Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
